174 related articles for article (PubMed ID: 9405903)
1. IDDM accompanied by a growth hormone-producing pituitary adenoma. A case report.
Otsuka F; Ogura T; Yamauchi T; Shikata K; Kageyama J; Makino H
Diabetes Care; 1997 Dec; 20(12):1838-41. PubMed ID: 9405903
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of acromegaly in a patient with type 1 diabetes mellitus.
Hofmann EA; Polonsky KS; Weiss RE
Endocr Pract; 2002; 8(2):113-8. PubMed ID: 11942776
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
4. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
Schwyzer L; Starke RM; Jane JA; Oldfield EH
J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276
[TBL] [Abstract][Full Text] [Related]
5. Case Report: A Case of Pituitary Adenoma Producing Growth Hormone and Thyroid-Stimulating Hormone Simultaneously.
Sanada J; Tatsumi F; Kamei S; Fushimi Y; Shimoda M; Kohara K; Nakanishi S; Kaku K; Mune T; Kaneto H
Front Endocrinol (Lausanne); 2021; 12():659076. PubMed ID: 33828533
[TBL] [Abstract][Full Text] [Related]
6. [Outcome of somatostatin analogue treatment in acromegaly].
Mondok A; Tóth M; Patócs A; Szücs N; Igaz P; Pusztai P; Czirják S; Beko G; Gláz E; Rácz K; Tulassay Z
Orv Hetil; 2009 Aug; 150(31):1457-62. PubMed ID: 19617182
[TBL] [Abstract][Full Text] [Related]
7. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.
Colao A; Attanasio R; Pivonello R; Cappabianca P; Cavallo LM; Lasio G; Lodrini A; Lombardi G; Cozzi R
J Clin Endocrinol Metab; 2006 Jan; 91(1):85-92. PubMed ID: 16263832
[TBL] [Abstract][Full Text] [Related]
8. Pituitary macroadenoma secreting thyrotropin and growth hormone: remission of bihormonal hypersecretion in response to lanreotide therapy.
Shimon I; Nass D; Gross DJ
Pituitary; 2001 Sep; 4(4):265-9. PubMed ID: 12501978
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of gamma knife surgery for growth hormone-producing pituitary adenoma: is the disease difficult to cure?
Kobayashi T; Mori Y; Uchiyama Y; Kida Y; Fujitani S
J Neurosurg; 2005 Jan; 102 Suppl():119-23. PubMed ID: 15662793
[TBL] [Abstract][Full Text] [Related]
10. Plurihormonal ACTH-GH Pituitary Adenoma: Case Report and Systematic Literature Review.
Roca E; Mattogno PP; Porcelli T; Poliani L; Belotti F; Schreiber A; Maffezzoni F; Fontanella MM; Doglietto F
World Neurosurg; 2018 Jun; 114():e158-e164. PubMed ID: 29501516
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous symptomatic Rathke's cleft cyst and GH secreting pituitary adenoma: a case report.
Bader LJ; Carter KD; Latchaw RE; Ellis WG; Wexler JA; Watson JC
Pituitary; 2004; 7(1):39-44. PubMed ID: 15638297
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of slow-release lanreotide in previously operated and untreated patients with GH-secreting pituitary macroadenoma.
Cannavò S; Squadrito S; Curtò L; Almoto B; Trimarchi F
Horm Metab Res; 2001 Oct; 33(10):618-24. PubMed ID: 11607883
[TBL] [Abstract][Full Text] [Related]
13. Transsphenoidal surgery for growth hormone-secreting pituitary adenomas in 130 patients.
Shirvani M; Motiei-Langroudi R
World Neurosurg; 2014 Jan; 81(1):125-30. PubMed ID: 23313263
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid-dependency on GH secretion and tumor growth in a GH-producing pituitary adenoma with Cushing's syndrome.
Uchida D; Tatsuno I; Nakamura S; Noguchi Y; Saito J; Tanaka T; Saito Y; Saeki N; Nishikawa T
Endocr J; 2000 Mar; 47 Suppl():S69-71. PubMed ID: 10890188
[TBL] [Abstract][Full Text] [Related]
15. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
[TBL] [Abstract][Full Text] [Related]
16. Composite somatotroph--ACTH-immunoreactive pituitary adenoma with transformation of hyperplasia to adenoma.
Mazarakis N; Kontogeorgos G; Kovacs K; Horvath E; Borboli N; Piaditis G
Pituitary; 2001 Sep; 4(4):215-21. PubMed ID: 12501971
[TBL] [Abstract][Full Text] [Related]
17. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
Gondim JA; Almeida JP; de Albuquerque LA; Gomes E; Schops M; Ferraz T
Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
[TBL] [Abstract][Full Text] [Related]
18. Quantification of specific growth patterns and frequency of the empty sella phenomenon in growth hormone-secreting pituitary adenomas.
Bier G; Hempel JM; Grimm F; Ernemann U; Bender B; Honegger J
Eur J Radiol; 2018 Jul; 104():79-86. PubMed ID: 29857870
[TBL] [Abstract][Full Text] [Related]
19. Double pituitary adenomas associated with persistent trigeminal artery: a rare case report and the review of literature.
Miyagi N; Doi R; Kuramoto T; Sakata K; Tahara S; Sugita Y; Morioka M
Neurosurg Rev; 2018 Jan; 41(1):341-345. PubMed ID: 29080054
[TBL] [Abstract][Full Text] [Related]
20. Gender-related differences in growth hormone-releasing pituitary adenomas. A clinicopathological study.
Schaller B
Pituitary; 2002; 5(4):247-53. PubMed ID: 14558673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
